Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interaction
Carmine Rocca, Anna De Bartolo, Fedora Grande, Bruno Rizzuti, Teresa Pasqua, Francesca Giordano, Maria Concetta Granieri, Maria Antonietta Occhiuzzi, Antonio Garofalo, Nicola Amodio, Maria Carmela Cerra, Francis Schneider, Maria Luisa Panno, Marie Hélène Metz-Boutigue, Tommaso Angelone
Topics & Concepts
CTL*TLR4InflammationOxidative stressLipopolysaccharideProinflammatory cytokineMAPK/ERK pathwayPharmacologyChemistryImmunologyBiologyImmune systemSignal transductionBiochemistryCD8Antimicrobial Peptides and ActivitiesImmune Response and InflammationBiochemical and Structural Characterization